Session: New Antimicrobials in the Pipeline Part 2
2015 - A Fully Human IgG Monoclonal Antibody (MAb) to the Microbial Surface Polysaccharide PNAG (Poly N-Acetyl Glucosamine): A Pathway for the Development of a Broad-Spectrum Antibody Therapeutic by Alopexx, Inc.